Diabetes Treatment Denied in Louisiana: Guide

Louisiana has one of the highest diabetes rates in the United States, with over 500,000 adults living with a diagnosed condition and a disproportionate burden falling on low-income, Black, and rural communities. The state's insurance landscape includes a large Medicaid population and a commercial market with significant barriers to newer diabetes treatments. If your Louisiana insurer has denied insulin, a CGM, an insulin pump, or GLP-1 medications like Ozempic or Mounjaro, understanding your appeal rights under Louisiana law is the essential first step.

The Louisiana Insurance Landscape for Diabetes

Major health insurers in Louisiana include Blue Cross Blue Shield of Louisiana (BCBSLA), Humana, Aetna, UnitedHealthcare, and Molina Healthcare. BCBSLA has a dominant market position in Louisiana's commercial insurance market. The HealthCare.gov marketplace serves Louisiana's individual plan purchasers.

Louisiana's Department of Insurance (LDI) regulates fully insured health plans sold in the state. Self-funded employer plans are governed by federal ERISA. Louisiana has fewer state-level insurance mandates than more progressive states, making federal ACA protections — including the essential health benefits requirement and prohibition on lifetime limits — especially important.

Louisiana's Insulin Cost-Cap Law

Louisiana enacted an insulin cost-cap law capping patient out-of-pocket costs for insulin at $35 per 30-day supply for state-regulated plans. If you are enrolled in a qualifying plan and paying above this threshold, contact the Louisiana Department of Insurance at 1-800-259-5300 or ldi.la.gov.

Medicaid (Healthy Louisiana / Medicaid Managed Care) and Diabetes

Louisiana's Medicaid program, Healthy Louisiana, is administered through managed care organizations: Aetna Better Health, AmeriHealth Caritas Louisiana, Humana Healthy Horizons, Louisiana Healthcare Connections (Centene), and UnitedHealthcare Community Plan. Louisiana expanded Medicaid under the ACA in 2016, extending coverage to hundreds of thousands of low-income adults.

Healthy Louisiana covers insulin, oral diabetes medications, blood glucose monitors, test strips, CGMs (with Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization), and insulin pumps. CGM prior authorization requires documentation of insulin use and clinical need. If your Healthy Louisiana MCO denied diabetes treatment, file a grievance with your MCO within 60 days. If unresolved, request a State Fair Hearing through the Louisiana Department of Health (LDH) at 1-888-342-6207.

Common Denials in Louisiana

GLP-1 Drugs (Ozempic, Mounjaro, Victoza, Trulicity): BCBSLA and other Louisiana carriers impose prior authorization and step therapy for GLP-1 agonists. Louisiana's commercial plans frequently deny Ozempic and Mounjaro by reclassifying them as weight-loss drugs even when prescribed for Type 2 diabetes. Ensure the prescription and prior authorization paperwork clearly specifies the diabetes indication (E11.65 or E11.9) and your endocrinologist or primary care provider documents the A1C level and the clinical need for GLP-1 therapy specifically for glycemic control.

CGMs: CGM denials are particularly common in Louisiana's commercial and Medicaid plans. Many plans apply outdated criteria requiring intensive insulin regimens (four or more injections daily) before approving a CGM. The ADA's 2024 Standards of Care recommend CGMs for all patients using insulin — basal or prandial — and for Type 2 patients at elevated risk of hypoglycemia. This is your primary citation for appeal.

Insulin Pumps: BCBSLA and Humana require documentation of MDI failure, A1C above goal despite optimal therapy, and an endocrinologist's attestation. Without an endocrinologist's involvement, pump approvals are rare. Seek a referral to an endocrinologist if you have not already done so.

Specialist Access: Louisiana has a shortage of endocrinologists, particularly outside Baton Rouge and New Orleans. If your plan denies out-of-network specialist care, request a network adequacy accommodation and document the absence of accessible in-network specialists.

Diabetes Education: Louisiana requires coverage of diabetes self-management education for state-regulated plans. If DSMT was denied, cite the Louisiana Insurance Code mandate directly.

How to Appeal a Diabetes Denial in Louisiana

1. Request your denial notice and the plan's clinical criteria for the denied treatment. Louisiana law requires insurers to provide written denial reasons.
2. Have your physician or endocrinologist write a detailed letter of medical necessity addressing the specific denial reason, citing ADA Standards of Care, cardiovascular outcome trial data for GLP-1 drugs, and your documented clinical history.
3. File an internal appeal within 180 days of the denial. Louisiana requires insurers to resolve standard appeals within 30 days and urgent appeals within 72 hours.
4. Request External Independent Review: Complete Guide" class="auto-link">external review through the Louisiana Department of Insurance if the internal appeal fails. Louisiana's external review process uses certified IROs) Explained" class="auto-link">independent review organizations, is free to patients, and is binding on the insurer.
5. File a complaint with the Louisiana Department of Insurance at 1-800-259-5300 or ldi.la.gov.

For Healthy Louisiana Medicaid denials, contact your MCO's member services or request a State Fair Hearing through the Louisiana Department of Health at 1-888-342-6207.

State Insurance Department Contact

Louisiana Department of Insurance (LDI)

• Consumer Hotline: 1-800-259-5300
• Website: ldi.la.gov

Louisiana Department of Health (LDH — Medicaid)

• Healthy Louisiana: 1-888-342-6207
• Website: ldh.la.gov/medicaid

Additional Resources

The American Diabetes Association (diabetes.org) provides Louisiana-specific advocacy resources and can connect patients with legal advocates experienced in insurance disputes. The Southeast Louisiana Legal Services (slls.org) provides free civil legal assistance to low-income Louisianans, including insurance and Medicaid appeals.

Louisiana's diabetes burden is among the highest in the nation, and insurance denials add an additional layer of harm to an already-challenging situation. The external review process gives patients a real, binding mechanism to challenge wrongful denials. Submit your appeal with complete clinical documentation and physician support — and don't accept the first denial as final.

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.

Fight your denial at ClaimBack →

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• What Is Step Therapy?